SCHEMBL2908751

SCHEMBL2908751

Cc1cc2cccc(Nc3nc4ccc[c]c4cc3C(N)=O)c2o1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 1/20 0.39
TP53 P04637 1/20 0.39
BLM P54132 1/20 0.39
KMT2A Q03164 1/20 0.39
EGFR P00533 1/20 0.38
KDR P35968 1/20 0.38
MRGPRX1 Q96LB2 1/20 0.37
SYK P43405 7/20 0.34
MAPT P10636 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
KDM4E B2RXH2 2/20 0.33
POLB P06746 1/20 0.33
LCK P06239 1/20 0.33
ADORA2A P29274 1/20 0.32
ADORA2B P29275 1/20 0.32
ADORA1 P30542 1/20 0.32
PARP1 P09874 1/20 0.32
IGF1R P08069 1/20 0.32
SIRT2 Q8IXJ6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2902472 0.73 NPY5R (0.41) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL3345725 0.71 KDM4E (0.47) ALDH1A1MEN1TP53KMT2ASMN1; SMN2
SCHEMBL19857573 0.68 LCK (0.50) ALDH1A1KMT2AMRGPRX1MAPTSMN1; SMN2
SCHEMBL2905910 0.63 AURKA (0.53) EGFRPARP1
SCHEMBL6114187 0.62 ALDH1A1 (0.50) ALDH1A1MEN1KMT2AMRGPRX1MAPT
SCHEMBL2905911 0.62 EGFR (0.39) EGFRADORA2A
SCHEMBL2908752 0.62 SLC2A1 (0.39) ALDH1A1MEN1BLMKMT2AEGFR
SCHEMBL14401689 0.61 ALDH1A1 (0.51) ALDH1A1MRGPRX1MAPTSMN1; SMN2KDM4E
SCHEMBL6114185 0.60 MAOA (0.43) ALDH1A1MEN1TP53KMT2AMRGPRX1
SCHEMBL23629063 0.59 IKBKB (0.58) ALDH1A1MEN1KMT2AEGFRSYK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7825253-B2 2-aminoquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2010-11-02 US claimed
EP-2076495-B1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES HOFFMANN LA ROCHE (CH) 2010-08-18 EP claimed
EP-2076495-A1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES F.HOFFMANN-LA ROCHE AG (CH) 2009-07-08 EP claimed
WO-2008037626-A1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES F. HOFFMANN-LA ROCHE AG (CH) 2008-04-03 WO claimed
US-20080081907-A1 2-AMINOQUINOLINE DERIVATIVES HOFFMANN-LA ROCHE INC. 2008-04-03 US claimed
US-7825253-B2 2-aminoquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2010-11-02 US disclosed
EP-2076495-B1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES HOFFMANN LA ROCHE (CH) 2010-08-18 EP disclosed
EP-2076495-A1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES F.HOFFMANN-LA ROCHE AG (CH) 2009-07-08 EP disclosed
WO-2008037626-A1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES F. HOFFMANN-LA ROCHE AG (CH) 2008-04-03 WO disclosed
US-20080081907-A1 2-AMINOQUINOLINE DERIVATIVES HOFFMANN-LA ROCHE INC. 2008-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080081907-A1 2-AMINOQUINOLINE DERIVATIVES AR, ADRA2C, RCC2 ALDH1A1 872/4885MEN1 645/4885TP53 2398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.